ConductScience.org, home

Paper20430010

3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines.

Qin JZ and 2 others. Biochem Biophys Res Commun, 2010. Cited by 45 papers, by iCite.

Cite this record

ConductScience Library. 3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines. Papers, record 20430010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20430010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines.
PubMed
Journal
Biochem Biophys Res Commun
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
1.21
iCite
Revised in PubMed
2015-11-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qin JZJ-Z
2Xin HH
3Nickoloff BJB J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApoptosisMajor topic
MelanomaMajor topic
PyruvatesMajor topic
Skin NeoplasmsMajor topic
Acetylcysteine
Adenosine Triphosphate
Cell Line, Tumor
Glutathione
Humans
Membrane Potential, Mitochondrial
Necrosis
Superoxides

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
40563683KAT/3BP: A Metabolism-Targeting Agent with Single and Combination Activity in Aggressive B-Cell Lymphomas.Cancers (Basel)2025https://conductscience.org/library/papers/40563683PubMed
365552893-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells.Int J Mol Sci2022https://conductscience.org/library/papers/36555289PubMed
35406733Mitochondrial Respiratory Complexes as Targets of Drugs: The PPAR Agonist Example.Cells2022https://conductscience.org/library/papers/35406733PubMed
33445795Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-Bromopyruvate.Int J Mol Sci2021https://conductscience.org/library/papers/33445795PubMed
30845728Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment.Cancers (Basel)2019https://conductscience.org/library/papers/30845728PubMed
30154655Enhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience.Int J Nanomedicine2018https://conductscience.org/library/papers/30154655PubMed
27457582The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside.J Bioenerg Biomembr2016https://conductscience.org/library/papers/27457582PubMed
26986252Hexokinase 2 is a determinant of neuroblastoma metastasis.Br J Cancer2016https://conductscience.org/library/papers/26986252PubMed
265309873-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system.J Bioenerg Biomembr2015https://conductscience.org/library/papers/26530987PubMed
26387611The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes.Sci Rep2015https://conductscience.org/library/papers/26387611PubMed
26266544Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells.PLoS One2015https://conductscience.org/library/papers/26266544PubMed
24636230Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.Chin J Cancer2014https://conductscience.org/library/papers/24636230PubMed
22802136D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects.J Bioenerg Biomembr2012https://conductscience.org/library/papers/22802136PubMed
22359102Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiae.J Bioenerg Biomembr2012https://conductscience.org/library/papers/22359102PubMed
22350013Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate.J Bioenerg Biomembr2012https://conductscience.org/library/papers/22350013PubMed
22328057Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug.J Bioenerg Biomembr2012https://conductscience.org/library/papers/22328057PubMed
22318358Flow cytometric evaluation of the effects of 3-bromopyruvate (3BP) and dichloracetate (DCA) on THP-1 cells: a multiparameter analysis.J Bioenerg Biomembr2012https://conductscience.org/library/papers/22318358PubMed
22318357Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells.J Bioenerg Biomembr2012https://conductscience.org/library/papers/22318357PubMed
222982553-Bromopyruvate: targets and outcomes.J Bioenerg Biomembr2012https://conductscience.org/library/papers/22298255PubMed
21921941D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate.Cancer Gene Ther2012https://conductscience.org/library/papers/21921941PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20430010

GET https://conductscience.org/api/papers/v1/20430010/cited_by?page=2